Psychedelics in PERIL: The Commercial Determinants of Health, Financial Entanglements and Population Health Ethics.
Public health ethics January 1, 2024 Daniel Buchman, Daniel Rosenbaum 8 citations
The for-profit psychedelic industry is starting to fund scientific research, mirroring practices from tobacco, alcohol, pharmaceutical, and food industries that have created conflicts of interest and harmed population health. Researchers face limited ethics guidance on accepting such sponsorship. A group of clinician scientists applied the PERIL ethical framework to a fictional case of corporate psychedelic funding, finding that financial ties can threaten a research program's purpose, autonomy, and integrity. The commercial determinants of health framework helps understand these industry-healthcare entanglements and offers a population health ethics lens for examining and addressing risks in the nascent psychedelic sector.